ArticleCell death discovery2026
Dysregulated nuclear Lamin B1 in DYT1 dystonia thickens nuclear lamina and disrupts 14-3-3 proteins.
Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Childhood-onset DYT1 dystonia is a severe movement disorder caused by a heterozygous ΔE mutation in TOR1A, yet the molecular mechanisms driving disease remain unclear. The nuclear lamina, a key structural scaffold for nuclear integrity and gene regulation, has emerged as a potential site of dysfunction. Here, we investigated the role of nuclear Lamin B1 dysregulation in DYT1 pathology using patient fibroblasts and human iPSC-derived neurons. We show that excess Lamin B1 thickens the nuclear lamina, distorts nuclear architecture, and impairs nucleocytoplasmic transport. Proteomic profiling further revealed that dysregulated Lamin B1 disrupts neuronal signaling pathways, with 14-3-3 proteins, highly abundant chaperones essential for neuronal development and homeostasis, being the most affected. Functional studies demonstrated that loss of 14-3-3 proteins compromises neuron differentiation, whereas restoring their levels rescues DYT1 neuronal defects by correcting Lamin B1 mislocalization. These findings establish a mechanistic link between nuclear architecture, intracellular signaling, and neuronal deficits in DYT1 dystonia, and identify Lamin B1 and 14-3-3 proteins as promising therapeutic targets with broader relevance to neurological disease.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.